Citations

Showing 10 of 108104 citations.

The incidence of lumbar spine surgery following Minimally Invasive Lumbar Decompression and Superion Indirect Decompression System for treatment of lumbar spinal stenosis: a retrospective review
Hagedorn, Jonathan M. , Yadav, Abhishek , D’Souza, Ryan S. , DeTemple, Nathan, Wolff, Jason S., Parmele, James B., Hagedorn, Jonathan M , D'Souza, Ryan S , Deer, Timothy R.

Mayo Clinic

Pain Practice | April 4, 2022 | Volume: 22 | Issue: 5 | Pages: 516-521

10.1111/papr.13111 | PMID 35373492 Get It

Abstract Introduction Lumbar spinal stenosis affects more than 200,000 adults in the United States, resulting in approximately 38,000 operations among the Medicare population and greater than $1.5 billion in hospital bills alone. Fortunately, Minimally Invasive Lumbar Decompression (MILD) and the Superion Indirect Decompression System have shown lasting benefit and cost savings compared to more aggressive surgical options. Objective Our primary objective was to retrospectively determine the rate of lumbar decompression surgery following the MILD and Superion procedures. Materials and Methods This was a pooled retrospective review of LSS patients who received MILD and/or Superion procedures between January 2011 and July 2019. Adult patients with CPT codes for MILD and Superion procedures were identified. Patients were included if they had a follow‐up visit at least 2 years from the procedure date, preprocedural MRI results, and surgical notes. Results A total of 199 patients were included in the final analysis, of which 57 patients (28.6%) underwent MILD procedure only, 124 patients (62.3%) underwent Superion only, and 18 patients (9.0%) underwent an MILD procedure initially followed by a Superion procedure. Two patients had an MILD procedure performed twice at the same level at separate encounters. A total of four patients in the entire cohort (2.0%; MILD 5.3%, Superion 0.8%) underwent subsequent lumbar spine surgery when followed for at least 2 years. It is notable that some of these patients may not have been surgical candidates and this may have skewed the results. Conclusions Patients undergoing minimally invasive decompression treatment of lumbar spinal stenosis have low rates of subsequent open surgery which potentially results in cost savings and a reduction in severe adverse events. The reason for low surgical rate may reflect improvement in their symptoms, a preference to avoid surgery, or being deemed not a surgical candidate.
Magnetic resonance venography
Glockner, James F., Lee, Christine U.

Mayo Clinic

Applied Radiology | April 4, 2022 | Volume: No volume available | Issue: No issue available | Pages: 36-42

10.37549/ar1758 Get It

International consensus statement on allergy and rhinology: Olfaction
Patel, Zara M. , Holbrook, Eric H. , Turner, Justin H. , Adappa, Nithin D. , Albers, Mark W. , Altundağ, Aytuğ , Appenzeller, Simone , Costanzo, Richard M. , Croy, Ilona , Davis, Greg E. , Dehgani‐Mobaraki, Puya , Doty, Richard L. , Haehner, Antje , Hopkins, Claire , Hummel, Thomas , Jitaroon, Kawinyarat, Kern, Robert C. , Khanwalkar, Ashoke , Kobayashi, Masayoshi , Leopold, Donald A., Levy, Joshua M. , Marmura, Michael J. , Mclelland, Lisha, Miwa, Takaki , Moberg, Paul J., Mueller, Christian A. , Nigwekar, Sagar U. , O’Brien, Erin K. , Păunescu, Teodor G. , Philpott, Carl , Pinto, Jayant M. , Reiter, Evan R. , Schlosser, Rodney J. , Schwob, James E. , Seiden, Allen M., Smith, Timothy L. , Sowerby, Leigh J. , Tan, Bruce K. , Thamboo, Andrew , Wrobel, Bozena , Yan, Carol H. , Duffy, Valerie B , Goldstein, Bradley J , Gudis, David A , Haehner, Antje , Higgins, Thomas S , Hopkins, Claire , Huart, Caroline , Hummel, Thomas , Kern, Robert C , Khanwalkar, Ashoke R , Kobayashi, Masayoshi , Kondo, Kenji , Lane, Andrew P , Levy, Joshua M , Marmura, Michael J , O'Brien, Erin K , Paunescu, Teodor G , Pellegrino, Robert , Philpott, Carl , Roalf, David R , Rowan, Nicholas R , Schlosser, Rodney J , Schwob, James , Smith, Timothy L , Sowerby, Leigh , Yan, Carol , Holbrook, Eric H , Patel, Zara , Albers, Mark W , Adappa, Nithin D. , Gudis, David A. , Lechner, Matt , Rowan, Nicholas R. , Soler, Zachary M.

Mayo Clinic

International Forum of Allergy & Rhinology | April 3, 2022 | Volume: 12 | Issue: 4 | Pages: 327-680

10.1002/alr.22929 | PMID 35373533 Get It

Abstract Background The literature regarding clinical olfaction, olfactory loss, and olfactory dysfunction has expanded rapidly over the past two decades, with an exponential rise in the past year. There is substantial variability in the quality of this literature and a need to consolidate and critically review the evidence. It is with that aim that we have gathered experts from around the world to produce this International Consensus on Allergy and Rhinology: Olfaction (ICAR:O). Methods Using previously described methodology, specific topics were developed relating to olfaction. Each topic was assigned a literature review, evidence‐based review, or evidence‐based review with recommendations format as dictated by available evidence and scope within the ICAR:O document. Following iterative reviews of each topic, the ICAR:O document was integrated and reviewed by all authors for final consensus. Results The ICAR:O document reviews nearly 100 separate topics within the realm of olfaction, including diagnosis, epidemiology, disease burden, diagnosis, testing, etiology, treatment, and associated pathologies. Conclusion This critical review of the existing clinical olfaction literature provides much needed insight and clarity into the evaluation, diagnosis, and treatment of patients with olfactory dysfunction, while also clearly delineating gaps in our knowledge and evidence base that we should investigate further.
Increased expression of syncytin-1 in skeletal muscle of humans with increased body mass index
Ravichandran, Jayachandran , Roust, Lori R., Katsanos, Christos S.

Mayo Clinic

No container title available | April 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-147911/v2 Get It

Abstract Obesity negatively impacts skeletal muscle protein metabolism, and also impairs skeletal muscle maintenance and regeneration. We analyzed muscle biopsy samples from humans with increased body mass index (BMI) (i.e. > 30 kg/m2) and controls (i.e., BMI < 25 kg/m2) for expression of syncytin-1, a fusogenic protein regulating skeletal muscle regeneration. When compared to controls, humans with increased BMI and concomitant reduction in muscle protein synthesis had higher expression of syncytin-1 in skeletal muscle (P < 0.05). Across human subjects, muscle protein synthesis correlated inversely (r = -0.51; P = 0.03) with syncytin-1 expression in muscle. Using a C2C12 cell line we found that expression of syncytin-A (i.e, corresponding protein in murine tissue) is increased by insulin, and that this response is impaired in the presence of fatty acids, whose metabolism is altered within the metabolic environment induced by increased BMI. In C2C12 cells, the response of the protein 4E-BP1, which signals increase in protein synthesis in muscle, resembled that of syncytin-A. These findings provide novel insights into the expression of syncytin-1 in skeletal muscle of humans with increased BMI, as well as its basic regulation by insulin and fatty acids in muscle. The findings signify the need for further research into the regulation of syncytin-1 in skeletal muscle of humans with increased BMI, as well as its biological implications for altering muscle protein metabolism and regeneration.
RCOM RADIOLOGICAL CASE OF THE MONTH
Emery, Robert L., Ly, Justin Q. , Beall, Douglas P. , Jones, Thomas P.

Mayo Clinic

Applied Radiology | April 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: 6-6

10.37549/ar1435 Get It

Normal variants and pitfalls in whole-body PET imaging with 18F FDG
Bogsrud, Trond Velde , Lowe, Val J.

Mayo Clinic

Applied Radiology | April 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: 16-30

10.37549/ar1432 Get It

RCOM RADIOLOGICAL CASE OF THE MONTH
Sullivan, Robert T., Hartman, R. C. , Campbell, Scot E., Q., Ly Justin, Hartman, Robert, Beall, Douglas P.

Mayo Clinic

Applied Radiology | April 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: 32-35

10.37549/ar1345 Get It

RCOM RADIOLOGICAL CASE OF THE MONTH
Waite, Christina, Kendell, Kurtis R., Ly, Justin Q. , Beall, Douglas P.

Mayo Clinic

Applied Radiology | April 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: 34-37

10.37549/ar1305 Get It

RCOM RADIOLOGICAL CASE OF THE MONTH
D., Kendell Scott, S., Collins Mark

Mayo Clinic

Applied Radiology | April 3, 2022 | Volume: No volume available | Issue: No issue available | Pages: 48-50

10.37549/ar1256 Get It

Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies
Mughal, Tariq I. , Pemmaraju, Naveen , Royston, Daniel , Valent, Peter , Patnaik, Mrinal M. , Fenaux, Pierre , Verstovšek, Srđan , Barbui, Tiziano , Etten, Richard A. Van , Verstovsek, Srdan , Valent, Peter , Bejar, Rafael , Gale, Robert Peter , Bose, Prithviraj , Kiladjian, Jean‐Jacques , Prchal, Josef T. , Pollyea, Daniel Aaron , Brümmendorf, Tim H. , Skórski, Tomasz , Santini, Valeria , Kucine, Nicole , Mesa, Ruben A. , Saglio, Giuseppe

Mayo Clinic

Hematological Oncology | April 3, 2022 | Volume: 40 | Issue: 4 | Pages: 491-504

10.1002/hon.2987 | PMID 35368098 Get It

Abstract Despite much of the past 2 years being engulfed by the devastating consequences of the SAR‐CoV‐2 pandemic, significant progress, even breathtaking, occurred in the field of chronic myeloid malignancies. Some of this was show‐cased at the 15th Post‐American Society of Hematology (ASH) and the 25th John Goldman workshops on myeloproliferative neoplasms (MPN) held on 9th‐10th December 2020 and 7th‐10th October 2021, respectively. The inaugural Post‐ASH MPN workshop was set out in 2006 by John Goldman (deceased) and Tariq Mughal to answer emerging translational hematology and therapeutics of patients with these malignancies. Rather than present a resume of the discussions, this perspective focuses on some of the pivotal translational hematology and therapeutic insights in these diseases.